The pharmacological profile and localization of somatostatin (SRIF) receptors were determined in rat, monkey and human cerebellum. In rat cerebellar cortex, low sst(1)/sst(4), intermediate sst(2) and very high sst(3) receptor mRNA levels were found. sst(1) mRNA was also expressed in the deep cerebellar nuclei [I-125]Tyr(3)-octreotide binding sites in cerebellar membranes correlated with recombinant sst(2), but not with sst(5) or sst(3) receptors and were found in the molecular layer of the cerebellum. [I-125]CGP 23996 (in Na+-buffer) binding in rat cerebellum correlated with sst(1) or sst(4), but not with sst(2), sst(3) or sst(5) receptor binding. Similar data were obtained in rhesus monkey cerebellum. mRNAs for all five receptors were found in the granule cell layer of the human cerebellum and/or in the dentate nucleus. [I-125]Tyr(3)-octreotide binding was strong in the molecular layer and correlated with that of recombinant sst(2) receptors, but not with sst(3) or sst(5) receptors. [I-125]CGP 23996 (in Mg++-buffer) binding was heterogeneous (about 75%. to sst(2) and 25% to sst(1) and/or sst(4) receptors). The molecular and granular layers were equally and the dentate nucleus strongly labeled. Thus, SRIF receptors of the sst(2), sst(1) and/or sst(4) subtype are present in the rat, monkey and human cerebellum. In the latter two species, the sst(2) type appears to be predominant. Surprisingly, the high expression of sst(3) receptor mRNA is not supported by radioligand binding data in any of the species studied. The reason for this discrepancy remains to be elucidated.
原文链接
分享
引用
